Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CDMO Solution Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Active Pharmaceutical Ingredient (API) Manufacturing
1.2.3 Finished Dosage Formulation (FDF) Development and Manufacturing
1.2.4 Secondary Packaging
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical CDMO Solution Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CDMO Solution Market Perspective (2018-2033)
2.2 Global Pharmaceutical CDMO Solution Growth Trends by Region
2.2.1 Pharmaceutical CDMO Solution Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pharmaceutical CDMO Solution Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical CDMO Solution Forecasted Market Size by Region (2024-2033)
2.3 Pharmaceutical CDMO Solution Market Dynamics
2.3.1 Pharmaceutical CDMO Solution Industry Trends
2.3.2 Pharmaceutical CDMO Solution Market Drivers
2.3.3 Pharmaceutical CDMO Solution Market Challenges
2.3.4 Pharmaceutical CDMO Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pharmaceutical CDMO Solution by Players
3.1.1 Global Pharmaceutical CDMO Solution Revenue by Players (2018-2023)
3.1.2 Global Pharmaceutical CDMO Solution Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical CDMO Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pharmaceutical CDMO Solution, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Pharmaceutical CDMO Solution Market Concentration Ratio
3.4.1 Global Pharmaceutical CDMO Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Solution Revenue in 2022
3.5 Global Key Players of Pharmaceutical CDMO Solution Head office and Area Served
3.6 Global Key Players of Pharmaceutical CDMO Solution, Product and Application
3.7 Global Key Players of Pharmaceutical CDMO Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CDMO Solution Breakdown Data by Type
4.1 Global Pharmaceutical CDMO Solution Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical CDMO Solution Forecasted Market Size by Type (2024-2033)
5 Pharmaceutical CDMO Solution Breakdown Data by Application
5.1 Global Pharmaceutical CDMO Solution Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical CDMO Solution Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pharmaceutical CDMO Solution Market Size (2018-2033)
6.2 North America Pharmaceutical CDMO Solution Market Size by Type
6.2.1 North America Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
6.2.2 North America Pharmaceutical CDMO Solution Market Size by Type (2024-2033)
6.2.3 North America Pharmaceutical CDMO Solution Market Share by Type (2018-2033)
6.3 North America Pharmaceutical CDMO Solution Market Size by Application
6.3.1 North America Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
6.3.2 North America Pharmaceutical CDMO Solution Market Size by Application (2024-2033)
6.3.3 North America Pharmaceutical CDMO Solution Market Share by Application (2018-2033)
6.4 North America Pharmaceutical CDMO Solution Market Size by Country
6.4.1 North America Pharmaceutical CDMO Solution Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Pharmaceutical CDMO Solution Market Size by Country (2018-2023)
6.4.3 North America Pharmaceutical CDMO Solution Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pharmaceutical CDMO Solution Market Size (2018-2033)
7.2 Europe Pharmaceutical CDMO Solution Market Size by Type
7.2.1 Europe Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
7.2.2 Europe Pharmaceutical CDMO Solution Market Size by Type (2024-2033)
7.2.3 Europe Pharmaceutical CDMO Solution Market Share by Type (2018-2033)
7.3 Europe Pharmaceutical CDMO Solution Market Size by Application
7.3.1 Europe Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
7.3.2 Europe Pharmaceutical CDMO Solution Market Size by Application (2024-2033)
7.3.3 Europe Pharmaceutical CDMO Solution Market Share by Application (2018-2033)
7.4 Europe Pharmaceutical CDMO Solution Market Size by Country
7.4.1 Europe Pharmaceutical CDMO Solution Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Pharmaceutical CDMO Solution Market Size by Country (2018-2023)
7.4.3 Europe Pharmaceutical CDMO Solution Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pharmaceutical CDMO Solution Market Size (2018-2033)
8.2 China Pharmaceutical CDMO Solution Market Size by Type
8.2.1 China Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
8.2.2 China Pharmaceutical CDMO Solution Market Size by Type (2024-2033)
8.2.3 China Pharmaceutical CDMO Solution Market Share by Type (2018-2033)
8.3 China Pharmaceutical CDMO Solution Market Size by Application
8.3.1 China Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
8.3.2 China Pharmaceutical CDMO Solution Market Size by Application (2024-2033)
8.3.3 China Pharmaceutical CDMO Solution Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Pharmaceutical CDMO Solution Market Size (2018-2033)
9.2 Asia Pharmaceutical CDMO Solution Market Size by Type
9.2.1 Asia Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
9.2.2 Asia Pharmaceutical CDMO Solution Market Size by Type (2024-2033)
9.2.3 Asia Pharmaceutical CDMO Solution Market Share by Type (2018-2033)
9.3 Asia Pharmaceutical CDMO Solution Market Size by Application
9.3.1 Asia Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
9.3.2 Asia Pharmaceutical CDMO Solution Market Size by Application (2024-2033)
9.3.3 Asia Pharmaceutical CDMO Solution Market Share by Application (2018-2033)
9.4 Asia Pharmaceutical CDMO Solution Market Size by Region
9.4.1 Asia Pharmaceutical CDMO Solution Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Pharmaceutical CDMO Solution Market Size by Region (2018-2023)
9.4.3 Asia Pharmaceutical CDMO Solution Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Recipharm AB
11.1.1 Recipharm AB Company Details
11.1.2 Recipharm AB Business Overview
11.1.3 Recipharm AB Pharmaceutical CDMO Solution Introduction
11.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.1.5 Recipharm AB Recent Developments
11.2 Lonza Group
11.2.1 Lonza Group Company Details
11.2.2 Lonza Group Business Overview
11.2.3 Lonza Group Pharmaceutical CDMO Solution Introduction
11.2.4 Lonza Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.2.5 Lonza Group Recent Developments
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Pharmaceutical CDMO Solution Introduction
11.3.4 Catalent Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.3.5 Catalent Recent Developments
11.4 Patheon (Thermo Fisher Scientific)
11.4.1 Patheon (Thermo Fisher Scientific) Company Details
11.4.2 Patheon (Thermo Fisher Scientific) Business Overview
11.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Introduction
11.4.4 Patheon (Thermo Fisher Scientific) Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.4.5 Patheon (Thermo Fisher Scientific) Recent Developments
11.5 Siegfried AG
11.5.1 Siegfried AG Company Details
11.5.2 Siegfried AG Business Overview
11.5.3 Siegfried AG Pharmaceutical CDMO Solution Introduction
11.5.4 Siegfried AG Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.5.5 Siegfried AG Recent Developments
11.6 SGS Quay Pharmaceuticals
11.6.1 SGS Quay Pharmaceuticals Company Details
11.6.2 SGS Quay Pharmaceuticals Business Overview
11.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Introduction
11.6.4 SGS Quay Pharmaceuticals Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.6.5 SGS Quay Pharmaceuticals Recent Developments
11.7 Curia
11.7.1 Curia Company Details
11.7.2 Curia Business Overview
11.7.3 Curia Pharmaceutical CDMO Solution Introduction
11.7.4 Curia Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.7.5 Curia Recent Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Pharmaceutical CDMO Solution Introduction
11.8.4 Thermo Fisher Scientific Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Developments
11.9 Samsung Biologics
11.9.1 Samsung Biologics Company Details
11.9.2 Samsung Biologics Business Overview
11.9.3 Samsung Biologics Pharmaceutical CDMO Solution Introduction
11.9.4 Samsung Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.9.5 Samsung Biologics Recent Developments
11.10 Fujifilm Diosynth Biotechnologies
11.10.1 Fujifilm Diosynth Biotechnologies Company Details
11.10.2 Fujifilm Diosynth Biotechnologies Business Overview
11.10.3 Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Introduction
11.10.4 Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.10.5 Fujifilm Diosynth Biotechnologies Recent Developments
11.11 Societal CDMO
11.11.1 Societal CDMO Company Details
11.11.2 Societal CDMO Business Overview
11.11.3 Societal CDMO Pharmaceutical CDMO Solution Introduction
11.11.4 Societal CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.11.5 Societal CDMO Recent Developments
11.12 Aenova Group
11.12.1 Aenova Group Company Details
11.12.2 Aenova Group Business Overview
11.12.3 Aenova Group Pharmaceutical CDMO Solution Introduction
11.12.4 Aenova Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.12.5 Aenova Group Recent Developments
11.13 Eurofins CDMO
11.13.1 Eurofins CDMO Company Details
11.13.2 Eurofins CDMO Business Overview
11.13.3 Eurofins CDMO Pharmaceutical CDMO Solution Introduction
11.13.4 Eurofins CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.13.5 Eurofins CDMO Recent Developments
11.14 Piramal Group
11.14.1 Piramal Group Company Details
11.14.2 Piramal Group Business Overview
11.14.3 Piramal Group Pharmaceutical CDMO Solution Introduction
11.14.4 Piramal Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.14.5 Piramal Group Recent Developments
11.15 WuXi AppTec Group
11.15.1 WuXi AppTec Group Company Details
11.15.2 WuXi AppTec Group Business Overview
11.15.3 WuXi AppTec Group Pharmaceutical CDMO Solution Introduction
11.15.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.15.5 WuXi AppTec Group Recent Developments
11.16 Fareva
11.16.1 Fareva Company Details
11.16.2 Fareva Business Overview
11.16.3 Fareva Pharmaceutical CDMO Solution Introduction
11.16.4 Fareva Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.16.5 Fareva Recent Developments
11.17 Strides Pharma Science
11.17.1 Strides Pharma Science Company Details
11.17.2 Strides Pharma Science Business Overview
11.17.3 Strides Pharma Science Pharmaceutical CDMO Solution Introduction
11.17.4 Strides Pharma Science Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.17.5 Strides Pharma Science Recent Developments
11.18 Famar Health Care Service
11.18.1 Famar Health Care Service Company Details
11.18.2 Famar Health Care Service Business Overview
11.18.3 Famar Health Care Service Pharmaceutical CDMO Solution Introduction
11.18.4 Famar Health Care Service Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.18.5 Famar Health Care Service Recent Developments
11.19 WuXi Biologics
11.19.1 WuXi Biologics Company Details
11.19.2 WuXi Biologics Business Overview
11.19.3 WuXi Biologics Pharmaceutical CDMO Solution Introduction
11.19.4 WuXi Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.19.5 WuXi Biologics Recent Developments
11.20 Asymchem
11.20.1 Asymchem Company Details
11.20.2 Asymchem Business Overview
11.20.3 Asymchem Pharmaceutical CDMO Solution Introduction
11.20.4 Asymchem Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.20.5 Asymchem Recent Developments
11.21 Pfizer CentreOne
11.21.1 Pfizer CentreOne Company Details
11.21.2 Pfizer CentreOne Business Overview
11.21.3 Pfizer CentreOne Pharmaceutical CDMO Solution Introduction
11.21.4 Pfizer CentreOne Revenue in Pharmaceutical CDMO Solution Business (2018-2023)
11.21.5 Pfizer CentreOne Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pharmaceutical CDMO Solution Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Active Pharmaceutical Ingredient (API) Manufacturing
Table 3. Key Players of Finished Dosage Formulation (FDF) Development and Manufacturing
Table 4. Key Players of Secondary Packaging
Table 5. Key Players of Others
Table 6. Global Pharmaceutical CDMO Solution Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Pharmaceutical CDMO Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Pharmaceutical CDMO Solution Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Pharmaceutical CDMO Solution Market Share by Region (2018-2023)
Table 10. Global Pharmaceutical CDMO Solution Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Pharmaceutical CDMO Solution Market Share by Region (2024-2033)
Table 12. Pharmaceutical CDMO Solution Market Trends
Table 13. Pharmaceutical CDMO Solution Market Drivers
Table 14. Pharmaceutical CDMO Solution Market Challenges
Table 15. Pharmaceutical CDMO Solution Market Restraints
Table 16. Global Pharmaceutical CDMO Solution Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Pharmaceutical CDMO Solution Revenue Share by Players (2018-2023)
Table 18. Global Top Pharmaceutical CDMO Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Solution as of 2022)
Table 19. Global Pharmaceutical CDMO Solution Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Pharmaceutical CDMO Solution Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Pharmaceutical CDMO Solution, Headquarters and Area Served
Table 22. Global Key Players of Pharmaceutical CDMO Solution, Product and Application
Table 23. Global Key Players of Pharmaceutical CDMO Solution, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Pharmaceutical CDMO Solution Revenue Market Share by Type (2018-2023)
Table 27. Global Pharmaceutical CDMO Solution Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Pharmaceutical CDMO Solution Revenue Market Share by Type (2024-2033)
Table 29. Global Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Pharmaceutical CDMO Solution Revenue Share by Application (2018-2023)
Table 31. Global Pharmaceutical CDMO Solution Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Pharmaceutical CDMO Solution Revenue Share by Application (2024-2033)
Table 33. North America Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Pharmaceutical CDMO Solution Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Pharmaceutical CDMO Solution Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Pharmaceutical CDMO Solution Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Pharmaceutical CDMO Solution Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Pharmaceutical CDMO Solution Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Pharmaceutical CDMO Solution Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Pharmaceutical CDMO Solution Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Pharmaceutical CDMO Solution Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Pharmaceutical CDMO Solution Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Pharmaceutical CDMO Solution Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Pharmaceutical CDMO Solution Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Pharmaceutical CDMO Solution Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Pharmaceutical CDMO Solution Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Pharmaceutical CDMO Solution Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Pharmaceutical CDMO Solution Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size by Country (2024-2033) & (US$ Million)
Table 65. Recipharm AB Company Details
Table 66. Recipharm AB Business Overview
Table 67. Recipharm AB Pharmaceutical CDMO Solution Product
Table 68. Recipharm AB Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 69. Recipharm AB Recent Developments
Table 70. Lonza Group Company Details
Table 71. Lonza Group Business Overview
Table 72. Lonza Group Pharmaceutical CDMO Solution Product
Table 73. Lonza Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 74. Lonza Group Recent Developments
Table 75. Catalent Company Details
Table 76. Catalent Business Overview
Table 77. Catalent Pharmaceutical CDMO Solution Product
Table 78. Catalent Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 79. Catalent Recent Developments
Table 80. Patheon (Thermo Fisher Scientific) Company Details
Table 81. Patheon (Thermo Fisher Scientific) Business Overview
Table 82. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product
Table 83. Patheon (Thermo Fisher Scientific) Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 84. Patheon (Thermo Fisher Scientific) Recent Developments
Table 85. Siegfried AG Company Details
Table 86. Siegfried AG Business Overview
Table 87. Siegfried AG Pharmaceutical CDMO Solution Product
Table 88. Siegfried AG Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 89. Siegfried AG Recent Developments
Table 90. SGS Quay Pharmaceuticals Company Details
Table 91. SGS Quay Pharmaceuticals Business Overview
Table 92. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product
Table 93. SGS Quay Pharmaceuticals Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 94. SGS Quay Pharmaceuticals Recent Developments
Table 95. Curia Company Details
Table 96. Curia Business Overview
Table 97. Curia Pharmaceutical CDMO Solution Product
Table 98. Curia Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 99. Curia Recent Developments
Table 100. Thermo Fisher Scientific Company Details
Table 101. Thermo Fisher Scientific Business Overview
Table 102. Thermo Fisher Scientific Pharmaceutical CDMO Solution Product
Table 103. Thermo Fisher Scientific Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 104. Thermo Fisher Scientific Recent Developments
Table 105. Samsung Biologics Company Details
Table 106. Samsung Biologics Business Overview
Table 107. Samsung Biologics Pharmaceutical CDMO Solution Product
Table 108. Samsung Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 109. Samsung Biologics Recent Developments
Table 110. Fujifilm Diosynth Biotechnologies Company Details
Table 111. Fujifilm Diosynth Biotechnologies Business Overview
Table 112. Fujifilm Diosynth Biotechnologies Pharmaceutical CDMO Solution Product
Table 113. Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 114. Fujifilm Diosynth Biotechnologies Recent Developments
Table 115. Societal CDMO Company Details
Table 116. Societal CDMO Business Overview
Table 117. Societal CDMO Pharmaceutical CDMO Solution Product
Table 118. Societal CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 119. Societal CDMO Recent Developments
Table 120. Aenova Group Company Details
Table 121. Aenova Group Business Overview
Table 122. Aenova Group Pharmaceutical CDMO Solution Product
Table 123. Aenova Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 124. Aenova Group Recent Developments
Table 125. Eurofins CDMO Company Details
Table 126. Eurofins CDMO Business Overview
Table 127. Eurofins CDMO Pharmaceutical CDMO Solution Product
Table 128. Eurofins CDMO Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 129. Eurofins CDMO Recent Developments
Table 130. Piramal Group Company Details
Table 131. Piramal Group Business Overview
Table 132. Piramal Group Pharmaceutical CDMO Solution Product
Table 133. Piramal Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 134. Piramal Group Recent Developments
Table 135. WuXi AppTec Group Company Details
Table 136. WuXi AppTec Group Business Overview
Table 137. WuXi AppTec Group Pharmaceutical CDMO Solution Product
Table 138. WuXi AppTec Group Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 139. WuXi AppTec Group Recent Developments
Table 140. Fareva Company Details
Table 141. Fareva Business Overview
Table 142. Fareva Pharmaceutical CDMO Solution Product
Table 143. Fareva Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 144. Fareva Recent Developments
Table 145. Strides Pharma Science Company Details
Table 146. Strides Pharma Science Business Overview
Table 147. Strides Pharma Science Pharmaceutical CDMO Solution Product
Table 148. Strides Pharma Science Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 149. Strides Pharma Science Recent Developments
Table 150. Famar Health Care Service Company Details
Table 151. Famar Health Care Service Business Overview
Table 152. Famar Health Care Service Pharmaceutical CDMO Solution Product
Table 153. Famar Health Care Service Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 154. Famar Health Care Service Recent Developments
Table 155. WuXi Biologics Company Details
Table 156. WuXi Biologics Business Overview
Table 157. WuXi Biologics Pharmaceutical CDMO Solution Product
Table 158. WuXi Biologics Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 159. WuXi Biologics Recent Developments
Table 160. Asymchem Company Details
Table 161. Asymchem Business Overview
Table 162. Asymchem Pharmaceutical CDMO Solution Product
Table 163. Asymchem Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 164. Asymchem Recent Developments
Table 165. Pfizer CentreOne Company Details
Table 166. Pfizer CentreOne Business Overview
Table 167. Pfizer CentreOne Pharmaceutical CDMO Solution Product
Table 168. Pfizer CentreOne Revenue in Pharmaceutical CDMO Solution Business (2018-2023) & (US$ Million)
Table 169. Pfizer CentreOne Recent Developments
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical CDMO Solution Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Pharmaceutical CDMO Solution Market Share by Type: 2022 VS 2033
Figure 3. Active Pharmaceutical Ingredient (API) Manufacturing Features
Figure 4. Finished Dosage Formulation (FDF) Development and Manufacturing Features
Figure 5. Secondary Packaging Features
Figure 6. Others Features
Figure 7. Global Pharmaceutical CDMO Solution Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Pharmaceutical CDMO Solution Market Share by Application: 2022 VS 2033
Figure 9. Pharmaceutical Company Case Studies
Figure 10. Biotechnology Company Case Studies
Figure 11. Others Case Studies
Figure 12. Pharmaceutical CDMO Solution Report Years Considered
Figure 13. Global Pharmaceutical CDMO Solution Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Pharmaceutical CDMO Solution Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Pharmaceutical CDMO Solution Market Share by Region: 2022 VS 2033
Figure 16. Global Pharmaceutical CDMO Solution Market Share by Players in 2022
Figure 17. Global Top Pharmaceutical CDMO Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Solution as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO Solution Revenue in 2022
Figure 19. North America Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Pharmaceutical CDMO Solution Market Share by Type (2018-2033)
Figure 21. North America Pharmaceutical CDMO Solution Market Share by Application (2018-2033)
Figure 22. North America Pharmaceutical CDMO Solution Market Share by Country (2018-2033)
Figure 23. United States Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Pharmaceutical CDMO Solution Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Pharmaceutical CDMO Solution Market Share by Type (2018-2033)
Figure 27. Europe Pharmaceutical CDMO Solution Market Share by Application (2018-2033)
Figure 28. Europe Pharmaceutical CDMO Solution Market Share by Country (2018-2033)
Figure 29. Germany Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Pharmaceutical CDMO Solution Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Pharmaceutical CDMO Solution Market Share by Type (2018-2033)
Figure 37. China Pharmaceutical CDMO Solution Market Share by Application (2018-2033)
Figure 38. Asia Pharmaceutical CDMO Solution Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Pharmaceutical CDMO Solution Market Share by Type (2018-2033)
Figure 40. Asia Pharmaceutical CDMO Solution Market Share by Application (2018-2033)
Figure 41. Asia Pharmaceutical CDMO Solution Market Share by Region (2018-2033)
Figure 42. Japan Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Pharmaceutical CDMO Solution Market Share by Country (2018-2033)
Figure 52. Brazil Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Pharmaceutical CDMO Solution Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 59. Lonza Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 60. Catalent Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 61. Patheon (Thermo Fisher Scientific) Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 62. Siegfried AG Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 63. SGS Quay Pharmaceuticals Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 64. Curia Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 66. Samsung Biologics Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 67. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 68. Societal CDMO Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 69. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 70. Eurofins CDMO Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 71. Piramal Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 72. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 73. Fareva Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 74. Strides Pharma Science Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 75. Famar Health Care Service Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 76. WuXi Biologics Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 77. Asymchem Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 78. Pfizer CentreOne Revenue Growth Rate in Pharmaceutical CDMO Solution Business (2018-2023)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed